A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis.
Ejemel M, Smith TG, Greenberg L, Carson WC, Lowe D, Yang Y, Jackson FR, Morgan CN, Martin BE, Kling C, Hutson CL, Gallardo-Romero N, Ellison JA, Moore S, Buzby A, Sullivan-Bolyai J, Klempner M, Wang Y.
Ejemel M, et al. Among authors: jackson fr.
Sci Rep. 2022 Jun 7;12(1):9403. doi: 10.1038/s41598-022-13527-0.
Sci Rep. 2022.
PMID: 35672343
Free PMC article.